Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/100899
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorStrange, G.en
dc.contributor.authorRose, M.en
dc.contributor.authorKermeen, F.en
dc.contributor.authorO'Donnell, C.en
dc.contributor.authorKeogh, A.en
dc.contributor.authorKotlyar, E.en
dc.contributor.authorGrigg, L.en
dc.contributor.authorBullock, A.en
dc.contributor.authorDisney, P.en
dc.contributor.authorDwyer, N.en
dc.contributor.authorWhitford, H.en
dc.contributor.authorTanous, D.en
dc.contributor.authorFrampton, C.en
dc.contributor.authorWeintraub, R.en
dc.contributor.authorCelermajer, D.en
dc.date.issued2015en
dc.identifier.citationInternal Medicine Journal, 2015; 45(9):944-950en
dc.identifier.issn1444-0903en
dc.identifier.issn1445-5994en
dc.identifier.urihttp://hdl.handle.net/2440/100899-
dc.description.abstractBackground The management of children with congenital heart disease, CHD, has improved over recent decades and several patients surviving with CHD into adulthood are increasing. In developed countries, there are now as many adults as there are children living with CHD. Pulmonary arterial hypertension, PAH, occurs in, of patients with CHD. Aim We aimed to understand the characteristics and outcomes of this emerging population. Methods We collected data retrospectively and prospectively from, contributing centres across Australia and New Zealand, . Patients were included if they had been diagnosed with PAH and CHD and had been seen once in an adult centre after, January, . Results Of, patients with CHD-PAH, were female and, were New York Heart Association functional class II or III at the time of adult diagnosis of PAH. Mean age at diagnosis of PAH in adulthood was, ., years, and on average, patients were diagnosed with PAH, years after symptom onset. All-cause mortality was, at, years, at, years and, at, years. One hundred and six patients, experienced, hospitalisations during, patient years of follow up. Eighty-nine per cent of patients were prescribed PAH specific therapy, mean exposure of, ., years, . Conclusions Adults with PAH and CHD often have this diagnosis made after significant delay, and have substantial medium-term morbidity and mortality. This suggests a need for children transitioning to adult care with CHD to be closely monitored for this complication.en
dc.description.statementofresponsibilityG. Strange, M. Rose, F. Kermeen, C. O'Donnell, A. Keogh, E. Kotlyar, L. Grigg, A. Bullock, P. Disney, N. Dwyer, H. Whitford, D. Tanous, C. Frampton, R. Weintraub and D.S. Celermajeren
dc.language.isoenen
dc.publisherWileyen
dc.rights© 2015 Royal Australasian College of Physiciansen
dc.subjectpulmonary arterial hypertension; PAH; congenital heart diseaseen
dc.titleA binational registry of adults with pulmonary arterial hypertension complicating congenital heart diseaseen
dc.typeJournal articleen
dc.identifier.rmid0030038981en
dc.identifier.doi10.1111/imj.12821en
dc.identifier.pubid188118-
pubs.library.collectionPsychology publicationsen
pubs.library.teamDS11en
pubs.verification-statusVerifieden
pubs.publication-statusPublisheden
Appears in Collections:Psychology publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.